FDA Communications In Flux As HHS Assesses Mission-Critical Activities

 
• By Sue Sutter and Derrick Gingery

As the US FDA determines what media inquiries it can respond to, HHS is deciding whether planned actions or meetings can move forward, depending on whether they are deemed mission-critical.

Wooden puzzle with question marks
The FDA is determining the activities it can communicate about to the public as it navigates limits imposed by the Trump Administration. (Shutterstock)

More from US FDA

More from Agency Leadership